Nature's Sunshine Products, Inc. (NATR) financial statements and ratios from SEC XBRL: revenue $480.14M (TTM), net margin 4.1%, revenue growth 5.7% YoY, P/E 13.2. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $480.14M |
| Net Margin | 4.1% |
| Revenue Growth (YoY) | 5.7% |
| EPS Growth (YoY) | 163.4% |
| FCF Growth (YoY) | 101.3% |
| P/E Ratio | 13.2 |
| EV / EBITDA | 3.0 |
| Price / Book | 1.49 |
| Price / Sales | 0.51 |
| FCF Yield | 2.5% |
| DCF Value (model) | $24.02 |
| DCF Upside vs Price | 67.5% |
| Altman Z-Score | 4.54 (safe) |
| Sector P/E (Healthcare) | 21.7 |
NATR overview · NATR earnings · NATR KPIs · NATR investor relations · NATR ownership · NATR peers · NATR filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.